Pexelizumab: ALXN and partner Procter & Gamble (PG, Cincinnati, Ohio) completed enrollment of 900 AMI patients in a placebo-controlled, dose-ranging internation

Alexion Pharmaceuticals Inc. (ALXN), New Haven, Conn.
Product: Pexelizumab

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE